Biocryst Pharmaceuticals (BCRX) Q4 2023 Earnings

26FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.31
-0.27
-0.23
-0.19

Details

Expected EPS
-0.245868
Actual EPS
-0.31
Surprise EPS
-0.06
Surprise Percent
+26.08%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of -0.31 per share for Q4 2023.

0 Comments

Share your thoughts